Multiple Myeloma: International Myeloma Foundation : ASH 2011: Dr. Siegel - Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial

back

ASH 2011: Dr. Siegel - Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial

David S. Siegel, MD, PhD
Hackensack University Medical Center
Hackensack, New Jersey, USA

	12.07.11
Be the first to comment Name Email Address URL Remember personal info? Comments (You may use HTML tags for style)	print share \| related articles

Be the first to comment